made fairli clear adjust tie almost entir already-known
medicaid variabl contrast minim unforeseen develop
relat commerci market remaind
stock vs larg reflect neg sentiment
head quarter continu theme saw unh
earn last week outlook like better investor fear
specif management note would still abl grow core ep within
long-term target albeit bia toward lower end initi contempl
hif headwind full-year pbm benefit think point ep
rang see figur wind grow core ep low-end target
hif headwind would posit differenti vs
take conserv view greater fair
expect initi ep guidanc estim unchang
medicaid call management attribut full-year guidanc revis
bp disenrol medicaid result state redetermin effort
compani indic public charg rule materi impact result
thu far post-cal convers management call hand state
outsiz exposur rule florida texa california remind ny judg
issu nation-wid injunct earlier month block rule go
effect see updat encouragingli compani note medicaid
improv sequenti basi remain optimist receiv
posit rate adjust next month
reiter ow continu view one compel name
coverag given acceler growth attract valuat vs peer histor
level reiter ow rate pt price-to-earnings ep estim
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight remain attract
growth stori multi-year earn visibl driven
launch new pbm ingeniorx
supplement opportun acceler
growth nearli everi aspect enterpris
includ commerci specialti group
medicar advantag high-acu medicaid
upsid case reflect increas earn visibl
new pbm contract higher expect
downsid case reflect risk associ
increas cost trend aggress commerci price
lower expect medicar growth lower
visibl earn new pbm contract
ern guidanceoper revenueapproxim bnapproxim bnapproxim bnapproxim bnpremium bn bn bn bn bnbenefit expens /- /- product bn bn bn bn bnsg /- /- gaingreat bngreater bngreater bngreater bnnet invest bninterest mnamort mneffect tax epsgreat epsgreat mnoper flowgreat bngreater bngreater bngreater bnshare bil /- /- /- /- bpsmembership insur medic membership benefitback-end barclay
inc annual incom statement mil ep compon ingeniorx net revenu net oper invest loss oper invest medic loss product oper expens ex one-tim oper addback oper incom oper oper tax rate minor interest oper check fulli dilut share barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
unless otherwis indic price sourc refinitiv reflect close price relev trade market may last
avail price time public
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
gd one analyst fundament credit coverag team member household financi interest debt
equiti secur issuer
ge one analyst fundament equiti coverag team member household financi interest debt
equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or relat
 barclay bank plc and/or affili receiv non-invest bank relat compens includ compens brokerag
servic applic issuer within past month
